Gedivumab (Influenza A virus hemagglutinine HA) - Onderzoeksgraad Biosimilar
Gecertificeerd

Gedivumab (Influenza A virus hemagglutinine HA) - Onderzoeksgraad Biosimilar

Catalog #: 10-828
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Gedivumab is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers) .

Immunogen

Homo sapiens / Influenza A virus hemagglutinin HA [Influenza A virus]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Infectious Disease

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG1-kappa

Other Product Names

MHAA4549A, RO6876802; RG7745

Beschrijving

Gedivumab (Influenza A virus hemagglutinine HA) - Onderzoeksgraad Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamGedivumab (Influenza A virus hemagglutinine HA) - Onderzoeksgraad Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer10-828